4603: India’s jet engine ambitions, Tata Sons' listing twist & a new weight-loss drug race| MC Editor's Picks

India eyes a fighter jet engine partnership with France’s Safran post-Operation Sindoor, as delays hit GE supplies. Tata Sons faces fresh scrutiny over its listing exemption bid, with former CJI U U Lalit weighing in. Novo Nordisk races to launch Wegovy in India’s growing weight-loss market. Plus, a monsoon-led market watch, Assam’s semiconductor push, SEBI’s block deal revamp, and the global family office pivot toward India.